Adebrelimab + Apatinib in Advanced HCC Post-Systemic Therapy

Clinical trial NCT07192848 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07192848
Sponsor: Song Peng
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Non-resectable

Start date: 2025-09-01
Primary completion: 2027-06-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.